Surrogacy medical eligibility: the law versus clinic rules
What determines eligibility?
A clinic’s acceptance is not a legal determination that a surrogacy programme is permitted. Conversely, meeting a statutory eligibility condition does not oblige a doctor to perform an embryo transfer. The decisive questions are: which country’s rules govern treatment, which participants and procedures they cover, whether a medical indication is required, and whether a refusal reflects binding law, clinical safety or an institution’s optional policy. For cross-border programmes, the country of treatment and the country where intended parents plan to establish parentage may apply different rules. This article is a decision framework, not a worldwide list of eligible applicants or a medical diagnosis.
Six distinct sources of requirements
Request the exact legal provision in force on the proposed treatment date, its application to the intended parents, gestational carrier and gamete providers, and the competent authority for any mandatory approval. Read statute together with implementing rules and amendments: neither a clinic webpage nor a professional guideline can change an express legal prohibition. Official guidance may explain administration without itself creating every eligibility criterion. A clinic can impose reasonable medical safeguards or decline a procedure within applicable law, but should identify them as clinical rules rather than falsely attributing them to legislation. Contractual forms record consent and arrangements; they cannot cure a missing statutory condition.
Practical hierarchy: what a rule can establish
| Source of requirement | What it can require or recommend | How to check its authority |
|---|---|---|
| Statute enacted by the legislature | Can set entry conditions, prohibitions, required authorisations and legally recognised participants. | Check the currently operative text, jurisdiction, commencement and any exceptions; do not rely on a sales summary. |
| Regulation or ministerial order | May prescribe medical indications, examinations, forms and procedural details when authorised under applicable law. | Verify the consolidated edition, clause number, date and whether the provision applies to this programme. |
| Government or regulator guidance | Explains supervisory expectations and sometimes mandatory duties arising elsewhere in legislation or licence conditions. | Separate what the document calls a legal duty from an example of good clinical practice. |
| Professional association recommendation | Suggests clinical screening, psychological support, age ranges or prior-pregnancy history. | Identify whether local legislation adopts it; otherwise do not present it as the universal legal threshold. |
| Clinic protocol | May cover infection screening, obstetric risk, counselling, records, laboratory techniques and acceptance capacity. | Ask for the written policy and the clinician’s reason; another licensed provider may assess differently without overriding the law. |
| Agreement and consent form | Records participant instructions, informed decisions and practical commitments. | Check mandatory forms and independent consent; a signed contract alone does not confer legal eligibility or parentage. |
Ukraine: legal medical indications and participant requirements
Ukraine provides a concrete statutory-regulatory example, not a rule for other countries. Section VI, paragraph 6.2 of Ministry of Health Order No. 787 lists indications for gestational surrogacy: absence of a uterus; specified uterine or cervical deformities preventing pregnancy; untreatable endometrial changes; serious somatic disease making pregnancy dangerous to the recipient’s health or life without affecting the future child’s health; or four or more unsuccessful assisted-reproduction attempts despite repeated transfer of high-quality embryos. A general preference not to carry a pregnancy is not itself among those enumerated grounds. Whether the patient’s records satisfy an individual category is a medical assessment; the law’s wording, not a clinic advertisement, sets the legal test.
Under the same Ukrainian Order, paragraph 6.1 also requires an intended parent’s genetic link to the child and excludes a direct genetic link between gestational carrier and child. Paragraph 6.4 describes an adult, legally capable carrier with her own healthy child, a voluntary written statement and no medical contraindications; paragraph 6.3 adds psychiatric examination. Paragraphs 6.10–6.11 specify document sets, including the carrier’s identification and child’s birth certificate, relevant marital-status and spouse-consent documents, the intended couple’s identification and marriage certificate, the ART application and a notarised copy of their written agreement. These are distinct tests: proving an indication does not waive carrier or documentary requirements. Current case-specific interpretation and later amendments still require local review. The Order also permits a close relative of the intended parents to carry the pregnancy, provided the remaining conditions, including the absence of a direct genetic link with the child, are satisfied. Paragraph 6.1 refers to a couple or one future parent for the genetic-link condition, while the document list in paragraph 6.11 is framed around a married couple and includes a marriage certificate. That wording does not, by itself, establish the complete eligibility or document pathway for a single intended parent; obtain current local legal advice rather than assuming approval or a ban.
England and Wales: mandatory tests and clinic arrangements
England and Wales illustrate a different structure. Department of Health and Social Care guidance explains that surrogacy carried out through a fertility clinic involves donor-related screening: intended parents providing genetic material undergo appropriate medical and infectious-disease tests, while the carrier’s medical and obstetric history and infection risks are evaluated. It describes a saline-infusion ultrasound as something the clinic may require. The same guidance says most clinics require counselling for the participants and some request confirmation of legal advice or a surrogacy agreement before treatment. These descriptions must not be collapsed into a single nationwide statutory medical-indication list. HFEA materials also address offering appropriate implications counselling and obtaining informed, voluntary consent; the legal basis and applicable licence standards should be checked separately. The HFEA also identifies a legal duty for licensed clinics to provide appropriate treatment information for informed consent; this must be distinguished from a particular clinic’s request for proof that a person obtained independent legal advice.
Professional standards are not statutes
For the United States, the American Society for Reproductive Medicine’s 2022 committee opinion is a useful example of clinical recommendations rather than uniform national surrogacy legislation. It recommends documenting why a gestational carrier is considered, assessing medical and psychological risks, and generally preferring carriers aged 21–45 who have previously experienced a term pregnancy. It expressly distinguishes its recommendations from FDA donor-related requirements and warns that state rules can be more restrictive. Thus a clinic’s reference to an ASRM age preference does not prove that every state bans a particular applicant or carrier. Whether a recommendation binds a facility depends on governing law, licensing obligations and the actual clinic protocol. The ASRM opinion also contemplates exceptional use of a carrier older than 45 with disclosure of the additional pregnancy risks; it does not confer a right to treatment or remove any applicable law or clinic safety rule.
Check each participant separately
Do not treat “the couple is eligible” as one medical question. For intended parents, establish the factual indication, any required marital or family-status criteria, identity, consent, and whether a genetic connection is compulsory in that jurisdiction. For the gestational carrier, check age and legal capacity, past pregnancies where required, independent medical fitness, infections, mental-health safeguards and valid voluntary consent. For egg or sperm providers, donor testing, genetic screening, identity and consent rules may differ from those for intended parents. A partner’s signature may be legally required in one country or requested by a clinic in another. The same person may pass one branch but fail another.
Evidence to request and prepare
Build a dated dossier rather than submitting a single unspecific “infertility certificate”. For the prospective parent who would carry the pregnancy, obtain medical history, diagnosis, imaging, specialist opinion, previous treatment records and embryo-transfer outcomes when a particular indication depends on them. For the carrier, request obstetric history, prior child’s evidence if the law requires it, relevant laboratory and medical assessments, and the required independent counselling or consent records. For all participants, identify the exact passports, civil-status evidence, genetic-source declarations, application forms and notarised instruments required locally. Obtain clear translations and authentication only where the competent recipient requires them. Ask the clinic to mark each document “law”, “licensing rule”, “clinical policy” or “contractual request”.
Two examples of different outcomes
Example one: a patient has undergone three failed transfers. A clinic may nevertheless discuss gestational surrogacy as a clinical option, but that fact alone does not meet the Ukrainian paragraph 6.2 pathway requiring four or more failed ART attempts with its additional embryo-quality conditions. Another statutory indication might apply, but must be established separately; the clinic cannot invent the fourth attempt. Example two: a carrier satisfies the documented legal age and prior-child criteria, yet a specialist considers a new pregnancy unsafe. Legal status does not remove the clinician’s obligation to assess risk, and a clinic’s refusal does not necessarily prove statutory ineligibility. The remedy depends on which ground actually controls.
If the clinic says no
Ask for a written, reasoned decision identifying who was assessed, which stage is blocked, the exact legal clause or clinic policy, the clinical facts used and any route to reassessment. If evidence is missing, supply the specified reports; if the clinic misquotes a rule, seek written clarification and advice from a locally qualified fertility lawyer. A second independent clinical opinion may help with disputed medical risk, but cannot override a binding prohibition. If the issue concerns regulated conduct or discrimination, assess the relevant complaint, regulator or court process and its deadlines under local law. Do not pressure a carrier to bypass screening or sign away healthcare autonomy. If refusal rests only on a discretionary clinic policy, ask whether reconsideration is possible or seek an assessment from another appropriately authorised provider; neither option bypasses binding law or clinical consent.
A safe sequence before proceeding
Before paying non-refundable sums or creating embryos, confirm the treatment location, provider permissions, each participant’s eligibility and whose records demonstrate the specific indication. Obtain the clinic’s screening list and refund or cancellation terms in writing. Separately ask counsel in the intended parents’ home country how legal parentage, birth records, nationality and the child’s travel documents would be addressed: medical clearance abroad does not settle those questions. Recheck amendments immediately before signing and before embryo transfer, especially if tests expire or the carrier changes. Keep consent, medical conclusions and payment records accessible to the people authorised to use them.
The practical rule is to run two independent checks, not search for one blanket approval: first identify legally mandatory indications, exclusions, participant status and documentation in the treatment jurisdiction; then identify the clinic’s justified safety, laboratory and counselling conditions. Record which requirement failed and why. Only after both are met should the parties make irreversible medical or financial commitments, with a separate plan for parentage and cross-border documentation. This is draft comparative guidance; its examples cannot replace current advice in the actual country and clinic.
Sources
Primary and official materials; these sources are specific to the named jurisdictions and do not establish global permission.
- Ukraine Ministry of Health Order No. 787, Procedure for Assisted Reproductive Technologies, Chapter VI
- UK Department of Health and Social Care, The Surrogacy Pathway (England and Wales; updated 3 October 2025)
- HFEA, Surrogacy: a factsheet (reviewed 16 June 2026)
- ASRM, Recommendations for practices using gestational carriers (2022)
